Congress Wealth Management LLC DE Cuts Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Congress Wealth Management LLC DE trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,051 shares of the specialty pharmaceutical company’s stock after selling 30,095 shares during the quarter. Congress […]

Related Keywords

United States ,Padmanabhp Bhatt ,Piper Sandler ,Dimensional Fund Advisors ,Securities Exchange Commission ,Supernus Pharmaceuticals Company Profile ,Quarter For Supernus Pharmaceuticals ,Loomis Sayles Co ,Armistice Capital ,Exchange Commission ,Nasdaq ,Norges Bank ,News Ratings For Supernus Pharmaceuticals Daily ,Polar Capital Holdings Plc ,Supernus Pharmaceuticals Inc ,Supernus Pharmaceuticals ,Supernus Pharmaceuticals Price Performance ,Congress Wealth Management ,Free Report ,Wealth Management ,Capital Holdings Plc ,Fund Advisors ,Get Free Report ,Supernus Pharmaceuticals Daily ,